Navigation Links
Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care
Date:8/5/2014

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China, even those used in clinical trials.

"Our new relationship with Quintiles to offer companion diagnostic testing services in China moves our mission, to improve the lives of all patients afflicted with cancer, a big step forward," said Doug Ward, VP and Companion Diagnostics Lifecycle Leader. "Our oncology pharma collaborators can now reach a large and growing number of patients that can benefit from clinical trial participation using targeted treatments and tests."

According to the World Health Organization (WHO)'s latest World Cancer Report, China had the highest rate of new cancer cases recorded globally in 2012 with 21.9%, or 3.07 million, and the trend is increasing, particularly in lung, liver, esophageal and stomach cancers1.  This underscores the growing need for patients in China to have in-country access to the most advanced tissue diagnostic testing and companion therapeutics in the industry, which starts with early phase clinical trials.

"It's been extremely important to Ventana that we find a strategic laboratory in China that will help us uphold the CAP testing standard of excellence set by our global com
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
2. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
3. Ventana Supports World Patient Safety Day, July 25
4. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
5. MedeAnalytics Receives Leadership Award from Ventana Research
6. Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions
7. Ventana and Barco revolutionize digital pathology viewing experience
8. Ventana and EMC join forces to take digital pathology into the world of Big Data
9. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
10. Ventana launches fully automated Gram Stain on the BenchMark Special Stains platform
11. Ventana to partner with Incyte on the development of Companion Diagnostic tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... CHICAGO, Ill. , June 1, 2015  AbbVie ... 2015 Healthcare Conference on Thursday, June 4, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:6/1/2015)... BOSTON , June 1, 2015 Symbiotix ... a $2.3 million Phase 2 Small Business Technology Transfer ... (NIH) National Institute of Allergy and Infectious Diseases (NIAID). ... is developing a novel class of molecular therapeutics ... lead clinical candidate, Polysaccharide A (PSA), is the first ...
(Date:6/1/2015)... N.J. , June 1, 2015  Elusys ... and Drug Administration (FDA) has accepted for filing ... Anthim® (obiltoxaximab) for the treatment and prevention of ... submitted on March 20, 2015. Anthim is a ... Stockpile, the U.S. government,s repository of critical medical ...
Breaking Medicine Technology:Symbiotix Biotherapies Announces $2.3 Million Award from NIH's National Institute of Allergy and Infectious Diseases (NIAID) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 3
... NEW YORK, April 18, 2012 Financial executives in ... excise tax and the burden of its related compliance ... bottom lines, according to a survey conducted by KPMG ... of respondents said their companies are already contemplating actions ...
... NEW YORK, April 18, 2012 ... initiates coverage on Pacira Pharmaceuticals ... price target $18.00. ... is a member of the ...
Cached Medicine Technology:KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 2KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 3
(Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into the NAPW VIP Professional Woman ... prestigious distinction for leadership in academics. With more than ... is the nation’s leading networking organization exclusively for professional ... important distinction,” said NAPW President Star Jones. “She is ...
(Date:6/1/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Woman of ... distinction for leadership in business. NAPW is the nation’s ... than 700,000 members and over 200 operating Local Chapters. ... honor,” said NAPW President Star Jones. “Her perseverance, work ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Selma Tansey as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in mental health. ... professional women, boasting more than 700,000 members and over ... Selma with this important honor," said NAPW President Star ...
(Date:6/1/2015)... Dr. Robert G. Schwartz , ... & Rehabilitation, P.A., has published a new article ... therapy for knees, and highlights it as a ... arthroscopy or knee joint replacement. , Dr. Schwartz, ... and Regenerative Medicine, writes that both autologus and ...
(Date:6/1/2015)... June 01, 2015 Ticket Down announces that ... NBA Western Conference Finals and now will face the Cleveland ... be held at the Oracle Arena in Oakland and the ... 2014-15 National Basketball Association season, the Golden State Warriors were ... a team that learned from their playoff failures from the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 3Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3
... The chief executive officer of a health authority in St. ... faulty tests that may have affected the care of ... the Eastern Health Regional Authority agreed that Eastern Health could ... knew about the hormone receptor tests. ,'I regret ...
... agreed on a $5-billion initiative with major banks to retrofit ... first such enterprise to combat climate change. ,Former ... week with a summit in New York attended by mayors ... discuss climate change. ,Clinton's initiative launched on Wednesday ...
... President A.P.J. Abdul Kalam Thursday stressed on the necessity ... to increase neuro activities of mentally challenged people. ... of Manovikas Kendra, a premier rehabilitation and research institute ... going on worldwide and it will take five to ...
... offered their first insights at research on a group ... will serve as models of typical childhood development. ... Health study suggest that healthy children perform better on ... was particularly true among children from low-income families. ...
... found that chemical relaxers used to straighten hair are not ... among African-American women. ,Hair relaxers can enter the ... are not fully monitored by the Food and Drug Administration, ... study named Black Womens Health Study was conducted by a ...
... In order to makeup for the loss of the ... hospitals run by state governments , the railways and ... from them to make them profit making units. ... Hindustan Antibiotics Limited, Bengal Chemicals and Pharmaceuticals Limited, Hindustan ...
Cached Medicine News:Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:World Cities Join Hands to Combat Climate Change 2Health News:Library Of Brains To Aid Study of Brain Development In Children 2Health News:Library Of Brains To Aid Study of Brain Development In Children 3Health News:Hair Relaxers Not Linked With Breast Cancer Risk 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
... SP Surgical Table combines innovation and design ... up to 1,000 lbs. You can safely ... normal and reverse orientation and have virtually ... patients.,The Amsco 3085 SP Table offers the ...
... 1st MPJ IMPLANT SYSTEM is a unique ... of the 1st metatarsal phalangeal joint resulting ... revision of a previous arthroplasty. The ... pain relief, superior function and longevity. ...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
Medicine Products: